Normal and chronic phase CML hematopoietic cells repopulate NOD/SCID bone marrow with different kinetics and cell lineage representation

Hematology Journal

Volumn 1, Issue 5, 2000, Pages 307-315

  Dazzi, Francesco ^a   Hasserjian, Robert ^b   Gordon, Myrtle Y ^a   Boecklin, Federica ^a   Cotter, Finbarr ^c   Corbo, Margherita ^c   Capelli, Debora ^a   Goldman, John M ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cell phenotype; CML; Growth kinetics; NOD SCID mice; Normal hematopoiesis

Indexed keywords

ANIMAL; ARTICLE; CANCER STEM CELL; CELL CYCLE; CELL LINEAGE; CYTOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GERMFREE ANIMAL; GRAFT SURVIVAL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAST CELL; MOUSE; MOUSE MUTANT; MYELOID LEUKEMIA; NONOBESE DIABETIC MOUSE; PATHOLOGY; RADIATION CHIMERA; TRANSPLANTATION; XENOGRAFT;

ANIMALS; CELL CYCLE; CELL LINEAGE; GRAFT SURVIVAL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC-PHASE; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MAST CELLS; MICE; MICE, INBRED NOD; MICE, SCID; RADIATION CHIMERA; SPECIFIC PATHOGEN-FREE ORGANISMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR STEM CELLS;

EID: 0034585920     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200051     Document Type: Article

References (26)

1. Greiner DL, Schultz LD, Yates J, Appel MC, Pedrizet G, Hesselton R, Schweitzer I, Beamer WG, Schultz KL, Pelsue SC, Leif JH, Rajan TV. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. American Journal of Pathology 146: 888, 1995.
2. Larochelle A, Vormoor J, Hanenberg H, Wang JCY, Bhatia M, Lapidot T, Moritz T, Murdoch B, Li Xiao X, Kato I, Williams DA, Dick JE. Identification of primitive human hematopietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nature Medicine 2: 1329, 1996.
3. Wang JCY, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured the quantitative in vivo SCID-repopulating cell assay. Blood 89: 3919, 1997.
4. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nature Medicine 4: 1038, 1998.
5. Cashman JD, Lapidot T, Wang JC, Doedens M, Shultz LD, Lansdorp P, Dick JE, Eaves CJ. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 89: 4307, 1997.
6. Udomsakdi C, Eaves CJ, Swolin B, Reid DS, Barnett M, Eaves AC. Rapid decline in chronic myeloid leukemia cells in long-term culture due to a defect at the stem cell level. Proceedings of the National Academy of Science USA 89: 6192, 1992.
7. Goldman JM, Shiota F, Th'ng KH, Orchard KH. Circulating granulocytic and erythroid progenitor cells in chronic granulocytic leukaemia. British Journal of Haematology 46: 7, 1980.
8. Marley SB, Lewis JL, Goldman JM, Gordon MY. Abnormal kinetics of colony formation by erythroid burst-forming units (BFU-E) in chronic myeloid leukemia. British Journal of Haematology 93: 878, 1996.
9. Gordon MY, Goldman JM. Cellular and molecular mechanisms in chronic myeloid leukaemia: biology and treatment. British Journal of Haematology 95: 10, 1996.
10. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hemopoietic cell. Nature Medicine 3: 730, 1997.
11. Lewis ID, McDiarmid LA, Samels LM, To LB, Hughes TP. Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells. Blood 91: 630, 1998.
12. Wang JC, Lapidot T, Cashman JD, Doedens M, Addy L, Sutherland DR, Nayar R, Laraya P, Minden M, Keating A, Eaves AC, Eaves CJ, Dick JE. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood 91: 2406, 1998.
13. Dazzi F, Capelli D, Hasserjian R, Cotter F, Corbo M, Poletti A, Chinswangwatanakul W, Goldman JM, Gordon MY. The kinetics and extent of engraftment of chronic myelogenous leukemia (CML) cells in NOD/SCID mice reflect the phase of the donor's disease: an in vivo model of CML biology. Blood 92: 1390, 1998.
14. Ichimaru M, Ishimaru T, Belsky JL. Incidence of leukemia in atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950-71. Radiation dose, years after exposure, age at exposure, and type of leukemia. Journal of Radiation Research (Tokyo) 19: 262, 1978.
15. Turhan AG, Humpries RK, Phillips GL, Eaves AC, Eaves CJ. Clonal hematopoiesis demonstrated by X-linked DNA polymorphisms after allogeneic bone marrow transplantation. New England Journal of Medicine 320: 1655, 1989.
16. Eaves CJ, Udomsakdi C, Cashman J, Barnett M, Eaves A. The biology of normal and neoplastic stem cells in CML. Leukemia & Lymphoma 11: 245, 1993.
17. Davey FR, Olson S, Kurec AS, Eastman-Abaya R, Gottlieb AJ, Mason DY. The immunophenotyping of extramedullary myeloid cell tumors in paraffin-embedded tissue sections. American Journal of Surgery and Pathology 12: 699, 1988.
18. Gatter KC, Cordell JL, Turley H, Heryet A, Kieffer N, Anstee DJ, Mason DY. The immunohistological detections of platelets, megakaryocytes and thrombi in routinely processed specimens. Histopathology 13: 257, 1988.
19. Grand FH, Marley SB, Chase A, Titley I, Healy L, Spencer A, Reiter A, Goldman JM, Gordon MY. BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase myeloid leukemia patients. Leukemia 11: 1486, 1997.
20. Carella AM, Lerma E, Corsetti MT, Dejana A, Basta P, Vassallo F, Abate M, Soracco M, Benvenuto F, Figari O, Podesta M, Piaggio G, Ferrara R, Sessarego M, Parodi C, Puzzuti M, Rubagotti A, Occhini D, Frassoni F. Autograting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia. Blood 93: 1534, 1999.
21. Agis H, Beil WH, Bankl HC, Fureder W, Sperr WR, Ghannadan M, Baghestanian M, Sillaber C, Bettelheim P, Lechner K, Valent P. Mast cell lineage involvement in myeloproliferative and myelodysplastic syndromes: diagnostic role of cell-immunophenotyping. Leukemia & Lymphoma 22: 187, 1996.
22. Gurish MF, Pear WS, Stevens RL, Scott ML, Sokol K, Ghildyal N, Webster MJ, Hu MJ, Austen KF, Baltimore D. Tissue-regulated differentiation and maturation of a v-abl-immortalized mast cell-committed progenitor. Immunity 3: 175, 1995.
23. Elefanty AG, Cory S. Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions. Molecular and Cellular Biology 12: 1755, 1992.
24. Kelliher MA, McLaughlin J, Witte ON, Rosenberg N. Induction of chronic myeloid leukemia-like syndrome in mice with v-abl and BCR/ABL. Proceedings of the National Academy of Science USA 87: 6649, 1980.
25. bcr/abl kinase in myeloid cells. British Journal of Haematology 94: 5, 1996.
26. Moore S, Haylock DN, Levesque JP, McDiarmid LA, Samels LM, To LB, Simmons PJ, Hughes TP. Stem factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34(+) cells. Blood 92: 2461, 1998.